HYPERTROPHIC CARDIOMYOPATHY MEDICAL SOCIETY (EIN 872235662) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

ANDREW WANG MD

Tax Period

2024-01-01 to 2024-12-31

HYPERTROPHIC CARDIOMYOPATHY MEDICAL SOCIETY, founded in 2021, is a small nonprofit in the Health Care sector that reported $622K in total revenue in fiscal year 2024. Revenue surged 119% from the prior year, signaling strong growth momentum. The organization ran a surplus of $507K, a strong 82% operating margin.

Mission

TO BRING TOGETHER AN INNOVATIVE AND PRODUCTIVE COMMUNITY OF PHYSICIANS, SCIENTISTS AND MEDICAL PROVIDERS DEDICATED TO IMPROVING THE DIAGNOSIS AND TREATMENT OF PEOPLE WITH HYPERTROPHIC CARDIOMYOPATHY THROUGH CLINICAL EXCELLENCE, RESEARCH AND EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $387,523

Program Service Revenue $233,831

Investment Income $0

Other Revenue $280

TOTAL REVENUE $621,634

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $91,878

Other Expenses $114,935

TOTAL EXPENSES $114,935

Year-over-Year Comparison

	2024	2023	Change
Revenue	$621,634	$283,553	+1.2%
Expenses	$114,935	$187,382	-0.4%
Net Income	$506,699	$96,171	+4.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AHMAD MASRI MD	DIRECTOR	N/A	Director	$0	$0	$0
ANDREW WANG MD	PRESIDENT	N/A	Officer Director	$0	$0	$0
ANJALI OWENS MD	DIRECTOR	N/A	Director	$0	$0	$0
ANNA WOO MD	DIRECTOR	N/A	Director	$0	$0	$0
CAROLYN HO MD	DIRECTOR	N/A	Director	$0	$0	$0
EUGENE BRAUNWALD MD	DIRECTOR	N/A	Director	$0	$0	$0
HUGH WATKINS MD	DIRECTOR	N/A	Director	$0	$0	$0
IACOPO OLIVOTTO MD	VICE PRESIDE	N/A	Officer Director	$0	$0	$0
JODIE INGLES MD	DIRECTOR	N/A	Director	$0	$0	$0
JUAN KASKI MD	DIRECTOR	N/A	Director	$0	$0	$0
MARTIN MARON MD	DIRECTOR	N/A	Director	$0	$0	$0
MATTHEW MARTINEZ MD	DIRECTOR	N/A	Director	$0	$0	$0
MILIND DESAI MD	DIRECTOR	N/A	Director	$0	$0	$0
NICK SMEDIRA MD	DIRECTOR	N/A	Director	$0	$0	$0
SARA SABERI MD	TREASURER	N/A	Officer Director	$0	$0	$0
SRIHARI NAIDU MD	DIRECTOR	N/A	Director	$0	$0	$0
STEVE OMMEN MD	DIRECTOR	N/A	Director	$0	$0	$0
THEODORE ABRAHAM MD	DIRECTOR	N/A	Director	$0	$0	$0
HEIDI SALISBURY NP	DIRECTOR	N/A	Director	$0	$0	$0
LISA SALBERG	DIRECTOR	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$621,634	$114,935	$896,279	$506,699
2023	$283,553	$187,382	$405,854	$96,171
2022	$451,102	$137,550	$292,080	$313,552

HYPERTROPHIC CARDIOMYOPATHY MEDICAL SOCIETY